Cell Metab (2013) 17(6):81937
Patients starting new therapies often undergo more imaging and laboratory testing, which may lead to earlier identification of previously undetected thyroid nodules
Do Not Self-Adjust Medication It can be tempting to reduce your levothyroxine dose yourself if you see a "normal" result while losing weight
Bimagrumab, a monoclonal antibody targeting activin type II receptors, has shown potential to increase lean mass while reducing fat mass
For patients who dont want to wait days for an asynchronous review, this speed is a real advantage
Semaglutide, known as Ozempic and Rybelsus, offers more flexibility with once-weekly injections and a once-daily oral formulation, making it a more convenient option for many patients